Current Research and Scholarly Interests
Dr. Amy Dobberfuhl, received a B.S. in Mechanical Engineering from North Carolina State University in 2004 and her M.D. from the University of North Carolina at Chapel Hill School of Medicine in 2010. She completed her residency training in Urology at Albany Medical College in New York in 2015. She then completed an ACGME fellowship in FPMRS (Neurourology & Voiding Dysfunction) in the Department of Urology at Stanford University in 2017. Following fellowship Dr. Dobberfuhl was appointed the faculty research position of Instructor in the Department of Urology at Stanford University. Dr. Dobberfuhl is supported by a NIH KL2 career development award starting 7/1/2016 and her practice is 25% clinical and 75% research. Primary research interests include overactive bladder, underactive bladder, urinary incontinence and urinary retention.
Dr. Dobberfuhl’s past basic science and clinical research interests have included: animal models of voiding and pelvic floor dysfunction (mouse, rat, rabbit), renal fibrosis and molecular cell signaling inflammatory pathways, pelvic floor ischemia, neuroanatomy and bladder tissue mechanics.
Dr. Dobberfuhl's current basic science and clinical translational research efforts for 2016-2018 are supported by the Stanford Clinical and Translation Science Award to Spectrum (NIH KL2 TR 001083). To complement her KL2 sponsored research activities and translational research goals, her work on underactive bladder is her thesis for an M.S. in Epidemiology and Clinical Research, anticipated 2018. Through a CIRM grant (2016-2017), in collaboration with Dr. Bertha Chen (PI), her laboratory is currently investigating a novel iPSC pSMC stem cell therapy for the treatment of radiation cystitis, project titled "Prevention of the Late Stage Adverse Effects of Radiation on the Bladder using Human Induced Pluripotent Stem Cells in a Rat Model of Radiation Cystitis". Through a SUFU grant (2015-2017), Dr. Dobberfuhl's research has explored the physiologic effect of the various onabotulinumtoxinA chemodenervation injection patterns in use today, project titled "Localization of OnabotulinumtoxinA and Cystometric Response Following Single versus Multiple Injections for the Treatment of Overactive Bladder in a Rat Model". Upcoming activities include a patient oriented research proposal to investigate the basic science mechanisms of underactive bladder and the creation of a benign urologic urine bio-repository for the identification of urine biomarkers of compensated and decompensated detrusor dysfunction. In collaboration with her basic science colleagues Dr. Bertha Chen (Urogynecology) and Dr. Edward Diaz (Pediatric Urology), Dr. Dobberfuhl's additional laboratory activities include exploring novel pharmacologic targets which may modulate lower urinary tract function and fibrosis.